ArticleAdvances in therapy2026

Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus.

Yehuda Handelsman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.